Stage iv pancreatic cancer Trials in Rochester, United States
Conditions / Stage iv pancreatic cancer / Rochester, United States
Research into Stage iv pancreatic cancer spans multiple therapeutic approaches and trial phases.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01537107 | Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery | COMPLETED | PHASE1 |
| NCT00577889 | Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Stage IV Pancreatic Cancer | COMPLETED | PHASE2 |
| NCT01658943 | Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy | COMPLETED | PHASE2 |
| NCT00735917 | Saracatinib in Treating Patients With Previously Treated Metastatic Pancreatic Cancer | COMPLETED | PHASE2 |
| NCT03412799 | Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer | COMPLETED | PHASE1 |
| NCT05631574 | Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer | TERMINATED | PHASE1 |
| NCT00617708 | S0727 Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery | COMPLETED | PHASE1/PHASE2 |
| NCT00052689 | Bortezomib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer | COMPLETED | PHASE2 |
| NCT00085371 | Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas | COMPLETED | PHASE2 |
| NCT01893294 | Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic Cancer | COMPLETED | PHASE1 |